Transcription factor binding and individual genetic risk for valproate teratogenicity
Alison Anderson, Piero Perucca, Elena Vianca, Daniel Sandvik, Ana Antonic‐Baker, Roland Krause, Dana Jazayeri, Alison Anne Hitchcock, Janet Elizabeth Graham, Marian Todaro, Torbjörn Tomson, Dina Battino, Emilio Perucca, Meritxell Martínez Ferri, Anne Maria Rochtus, , Sameer M. Zuberi
The paper investigates how genetic variants affecting transcription factor binding contribute to valproate-induced birth defects and identifies EP300 as a key regulator involved in this process.
Neurology · Jan 14, 2026Peer-reviewedGenetic & Genomic Medicine